Robert Matthew Burkes , MD,MSCR

Dr. Robert Matthew Burkes is an instructor in pulmonary and critical care at the University of Cincinnati. Dr. Burkes’ clinical interests involve COPD, advanced asthma, asthma-COPD overlap, and alpha-1 antitrypsin disease.
 

Bachelor's Degree: Allegheny College Meadville, PA, 2009 (Undergraduate, graduated magna cum laude, Chemistry/Minor in History)

Medical Degree: The University of Toledo Toledo, OH, 2013

Residency: University of Louisville Louisville, KY, 2016 (Internal Medicine)

Fellowship: University of North Carolina Chapel Hill, NC, 2019 (Pulmonary Diseases and Critical Care Medicine)

Master's Degree: University of North Carolina Gillings School Chapel Hill, NC, 2020 (Clinical Research)

American Board of Internal Medicine (Certification Date: 08-25-2016 )

American Board of Internal Medicine (Pulmonary Disease) (Certification Date: 11-21-2019 )

American Board of Internal Medicine (Critical Care Medicine) (Certification Date: 11-28-2022 )

Asthma

Critical Care Medicine

Lung Disease

Pulmonary Disease

Airway Disorders

Aspergillosis

Bronchial Disease

Chronic Bronchitis

Chronic Cough

Chronic Obstructive Pulmonary Disease (COPD)

Dyspnea

Emphysema

Hemoptysis

Histoplasmosis

Legionnaires' Disease (Legionellosis)

Pleurisy

Pneumonia

Pulmonary Emphysema

Respiration Disorders

Respiratory Syncytial Virus (RSV)

Respiratory Tract Disease

Respiratory Tract Infections

Shortness of Breath

Thoracic Disease

Triad Asthma

Tuberculosis

Whooping Cough (Pertussis)

Critical Care Medicine

Internal Medicine

07-01-2019 -06-30-2020 Clinical Instructor, University of North Carolina at Chapel Hill, Chapel Hill, NC

Grant: #RIN PH 304 Investigators:Burkes, Robert 10-04-2021 -10-03-2024 Lung Biotechnology A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients with Pulmonary Hypertension due to Chronic Obstructive.. Role:PI 654295.17 Hold Level:Industry

Grant: #BP43098 Investigators:Burkes, Robert -09-30-2025 Genentech, Inc. PHASE Ib, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE SAFETY OF RO7486967 IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Role:PI 0.00 Hold Level:Industry

Grant: #EFC16819 Investigators:Burkes, Robert 01-11-2023 -01-10-2026 Sanofi US Services Inc. Randomized, double-blind, placebo-controlled, parallel group Phase 3 study to evaluate the efficacy, safety, and tolerability of SAR440340/REGN3500/itepekimab (anti-IL-33 mAb) in patients with modera Role:PI 5795762.21 Hold Level:Industry

Investigators:Burkes, Robert 04-05-2024 -04-02-2027 International Grants Administration, Inc. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, safety, and tolerability of dexpramipexoleadministered orally for 24 weeks in participants with eosinoph Role:PI 207541.91 Hold Level:Industry

Grant: #AR-DEX-22-01 Investigators:Burkes, Robert 04-05-2024 -04-04-2027 Areteia Therapeutics A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, safety, and tolerability of dexpramipexole administered orally for 52 weeks in participantswith severe Role:PI 214624.90 Hold Level:Industry

Peer Reviewed Publications

Burkes, Robert M; Ceppe, Agathe S; Doerschuk, Claire M; Couper, David; Hoffman, Eric A; Comellas, Alejandro P; Barr, R Graham; Krishnan, Jerry A; Cooper, Christopher; Labaki, Wassim W; Ortega, Victor E; Wells, J Michael; Criner, Gerard J; Woodruff, Prescott G; Bowler, Russell P; Pirozzi, Cheryl S; Hansel, Nadia N; Wise, Robert A; Brown, Todd T; Drummond, M Bradley (2020. ) Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort.Chest, , 157 (4 ) ,856-865 More Information

Wells, J Michael; Xing, Dongqi; Viera, Liliana; Burkes, Robert M; Wu, Yixin; Bhatt, Surya P; Dransfield, Mark T; Couper, David J; O'Neal, Wanda; Hoffman, Eric A; Gaggar, Amit; Barjaktarevic, Igor; Curtis, Jeffrey L; Labaki, Wassim W; Han, Mei Lan K; Freeman, Christine M; Putcha, Nirupama; Schlange, Thomas; Blalock, J Edwin (2019. ) The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS.Respiratory research, , 20 (1 ) ,254 More Information

Burkes, Robert M; Drummond, Michael B (2019. ) Initiating drug therapy in early stage chronic obstructive pulmonary disease: does it impact the course and outcome?.Current opinion in pulmonary medicine, , 25 (2 ) ,132-137 More Information

Burkes, Robert M; Astemborski, Jacquie; Lambert, Allison A; Brown, Todd T; Wise, Robert A; Kirk, Gregory D; Drummond, M Bradley (2019. ) Plasma cathelicidin and longitudinal lung function in current and former smokers.PloS one, , 14 (2 ) ,e0212628 More Information

Burkes, Robert M; Mkorombindo, Takudzwa; Chaddha, Udit; Bhatt, Alok; El-Kersh, Karim; Cavallazzi, Rodrigo; Kubiak, Nancy (2018. ) Impact of Quality Improvement on Care of Chronic Obstructive Pulmonary Disease Patients in an Internal Medicine Resident Clinic.Healthcare (Basel, Switzerland), , 6 (3 ) , More Information

Burkes, Robert M; Donohue, James F (2018. ) An Update on the Global Initiative for Chronic Obstructive Lung Disease 2017 Guidelines With a Focus on Classification and Management of Stable COPD.Respiratory care, , 63 (6 ) ,749-758 More Information

Burkes, Robert M; Gassett, Amanda J; Ceppe, Agathe S; Anderson, Wayne; O'Neal, Wanda K; Woodruff, Prescott G; Krishnan, Jerry A; Barr, R Graham; Han, MeiLan K; Martinez, Fernando J; Comellas, Alejandro P; Lambert, Allison A; Kaufman, Joel D; Dransfield, Mark T; Wells, J Michael; Kanner, Richard E; Paine, Robert; Bleecker, Eugene R; Paulin, Laura M; Hansel, Nadia N; Drummond, M Bradley (2018. ) Rural Residence and COPD Exacerbations: Analysis of the SPIROMICS Cohort.Annals of the American Thoracic Society, , More Information

Pfister, Gregory J; Burkes, Robert M; Guinn, Brian; Steele, Jacquelene; Kelley, Robert R; Wiemken, Timothy L; Saad, Mohamed; Ramirez, Julio; Cavallazzi, Rodrigo (2016. ) Opioid overdose leading to intensive care unit admission: Epidemiology and outcomes.Journal of critical care, , 35 ,29-32 More Information

McGrady, Angele; Burkes, Robert; Badenhop, Dalynn; McGinnis, Ron (2014. ) Effects of a brief intervention on retention of patients in a cardiac rehabilitation program.Applied psychophysiology and biofeedback, , 39 (3-4 ) ,163-70 More Information

Mathioudakis, Alexander G; Sivapalan, Pradeesh; Papi, Alberto; Vestbo, Jørgen (2020. ) The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision.The European respiratory journal, , 56 (1 ) , More Information

Burkes, Robert M; Ceppe, Agathe S; Couper, David J; Comellas, Alejandro P; Wells, J Michael; Peters, Stephen P; Criner, Gerard J; Kanner, Richard E; Paine, Robert; Christenson, Stephanie A; Cooper, Christopher B; Barjaktarevic, Igor Z; Krishnan, Jerry A; Labaki, Wassim W; Han, MeiLan K; Curtis, Jeffrey L; Hansel, Nadia N; Wise, Robert A; Drummond, M Bradley (2020. ) Plasma Cathelicidin is Independently Associated with Reduced Lung Function in COPD: Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.Chronic obstructive pulmonary diseases (Miami, Fla.), , 7 (4 ) ,370-381 More Information

Burkes, Robert M; Couper, David J; Barjaktarevic, Igor Z; Cooper, Christopher B; Labaki, Wassim W; Han, Meilan K; Woodruff, Prescott G; Lazarus, Stephen C; Parekh, Trisha M; Paine, Robert; Comellas, Alejandro P; Bowler, Russell P; Loehr, Laura R; Putcha, Nirupama; Wise, Robert A; Brown, Todd T; Drummond, M Bradley (2021. ) Age-Dependent Associations Between 25-Hydroxy Vitamin D Levels and COPD Symptoms: Analysis of SPIROMICS.Chronic obstructive pulmonary diseases (Miami, Fla.), , 8 (2 ) ,277-291 More Information

Mandru, Rachana; Zhou, Christine Y; Pauley, Rachel; Burkes, Robert M (2021. ) Considerations for and Mechanisms of Adjunct Therapy in COPD.Journal of clinical medicine, , 10 (6 ) , More Information

Burkes, Robert M; Panos, Ralph J; Borchers, Michael T (2021. ) How might endotyping guide chronic obstructive pulmonary disease treatment? Current understanding, knowledge gaps and future research needs.Current opinion in pulmonary medicine, , 27 (2 ) ,120-124 More Information

Burkes, Robert M; Panos, Ralph J (2020. ) Ultra Long-Acting ?-Agonists in Chronic Obstructive Pulmonary Disease.Journal of experimental pharmacology, , 12 ,589-602 More Information

Burkes, Robert; Pfister, Gregory; Guinn, Brian; Cavallazzi, Rodrigo (2017. ) Opioid overdose leading to intensive care unit admission: Epidemiology and outcomes.Journal of critical care, , 37 ,261 More Information

Burkes, Robert; Osterburg, Andrew; Hwalek, Timothy; Lach, Laura; Panos, Ralph J; Borchers, Michael T (2021. ) Cytomegalovirus Seropositivity is Associated with Airflow Limitation in a Cohort of Veterans with a High Prevalence of Smoking.Chronic obstructive pulmonary diseases (Miami, Fla.), , More Information

Sanders, Emily C; Burkes, Robert M; Mock, Jason R; Brown, Todd T; Wise, Robert A; Hansel, Nadia N; Liu, Mark C; Drummond, M Bradley (2021. ) Bronchoalveolar Lavage and Plasma Cathelicidin Response to 25-Hydroxy Vitamin D Supplementation: A Pilot Study.Chronic obstructive pulmonary diseases (Miami, Fla.), , 8 (3 ) ,371-381 More Information

Academic - 231 Albert Sabin Way
Cincinnati  Ohio, 45267
Phone: 513-558-4831
Fax: 513-558-4858
burkesrt@ucmail.uc.edu